CELGENE THALIDOMIDE Trademark

Trademark Overview

On Monday, June 21, 2010, a trademark application was filed for CELGENE THALIDOMIDE with the United States Patent and Trademark Office. The USPTO has given the CELGENE THALIDOMIDE trademark a serial number of 85067820. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 30, 2018. This trademark is owned by Celgene Corporation. The CELGENE THALIDOMIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, cytokine inhibitory drugs that contain thalidomide; pharmaceutical preparations used to treat cancers and immune related diseases that contain thalidomide
celgene thalidomide

General Information

Serial Number85067820
Word MarkCELGENE THALIDOMIDE
Filing DateMonday, June 21, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 30, 2018
Registration Number4014787
Registration DateTuesday, August 23, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 7, 2011

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THALIDOMIDE"
Description of MarkThe mark consists of a swirl design enclosed in a square with the words "CELGENE THALIDOMIDE".
Goods and ServicesPharmaceutical preparations, namely, cytokine inhibitory drugs that contain thalidomide; pharmaceutical preparations used to treat cancers and immune related diseases that contain thalidomide

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 30, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, March 30, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, August 23, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 23, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, June 7, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2011PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 3, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, May 3, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, May 3, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 3, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, May 3, 2011EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 3, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2011NON-FINAL ACTION E-MAILED
Tuesday, May 3, 2011NON-FINAL ACTION WRITTEN
Monday, April 11, 2011PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, March 26, 2011WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 15, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 15, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 15, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 10, 2011TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 9, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 9, 2011FINAL REFUSAL E-MAILED
Wednesday, February 9, 2011FINAL REFUSAL WRITTEN
Wednesday, January 19, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 19, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 14, 2011ASSIGNED TO LIE
Tuesday, December 28, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 27, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 27, 2010NON-FINAL ACTION E-MAILED
Monday, September 27, 2010NON-FINAL ACTION WRITTEN
Monday, September 27, 2010ASSIGNED TO EXAMINER
Friday, June 25, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Thursday, June 24, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 24, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

thalidomide celgene pharmaceutical contain preparations cancers immune related diseases treat used